| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.76▲ | 1.77▲ | 1.78▲ | 1.79▲ | 2.08▼ |
| MA10 | 1.79▲ | 1.79▼ | 1.80▼ | 1.87▼ | 3.08▼ |
| MA20 | 1.80▼ | 1.81▼ | 1.83▼ | 2.19▼ | 3.87▼ |
| MA50 | 1.83▼ | 1.84▼ | 1.86▼ | 3.32▼ | 9.54▼ |
| MA100 | 1.83▼ | 2.04▼ | 2.16▼ | 4.06▼ | 288.59▼ |
| MA200 | 2.09▼ | 2.53▼ | 2.97▼ | 6.72▼ | 351.99▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.004▼ | -0.002▼ | 0.021▲ | 1.675▲ |
| RSI | 47.933▼ | 45.277▼ | 44.175▼ | 29.403▼ | 31.650▼ |
| STOCH | 34.203 | 41.656 | 29.642 | 34.297 | 7.860▼ |
| WILL %R | -30.435 | -36.000 | -50.000 | -70.000 | -88.136▼ |
| CCI | -8.408 | -40.680 | -55.925 | -59.221 | -114.843▼ |
|
Thursday, September 03, 2026 07:19 AM
The early RAINIER data showed a 79% CR/CRi rate in evaluable frontline TP53-mutated AML patients, comparing favorably with a published 41% composite remission benchmark for venetoclax plus azacitidine ...
|
|
Monday, August 24, 2026 02:02 AM
Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company's recently ...
|
|
Wednesday, January 14, 2026 03:09 AM
The average one-year price target for Aptevo Therapeutics (NasdaqCM:APVO) has been revised to $7,711.20 / share. This is an increase of 1,700.00% from the prior estimate of $428.40 dated December 18, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/09/26 | 1.79 | 1.79 | 1.74 | 1.79 | 13,434 |
| 15/09/26 | 1.81 | 1.84 | 1.71 | 1.71 | 48,827 |
| 14/09/26 | 1.8538 | 1.895 | 1.80 | 1.80 | 46,080 |
| 11/09/26 | 1.83 | 1.92 | 1.80 | 1.82 | 42,825 |
| 10/09/26 | 1.82 | 1.88 | 1.76 | 1.83 | 56,482 |
| 09/09/26 | 1.89 | 1.99 | 1.82 | 1.845 | 43,909 |
| 08/09/26 | 1.77 | 1.93 | 1.7447 | 1.88 | 167,813 |
| 04/09/26 | 1.74 | 1.7961 | 1.64 | 1.74 | 271,120 |
| 03/09/26 | 2.11 | 2.18 | 1.37 | 1.71 | 1,662,141 |
| 02/09/26 | 2.34 | 2.77 | 2.33 | 2.60 | 959,708 |
|
|
||||
|
|
||||
|
|